No connection

Search Results

BSTZ vs TCBK

BSTZ
BlackRock Science and Technology Term Trust
BEARISH
Price
$22.64
Market Cap
$1.6B
Sector
Financial Services
AI Confidence
78%
TCBK
TriCo Bancshares
BULLISH
Price
$50.00
Market Cap
$1.61B
Sector
Financial Services
AI Confidence
80%

Valuation

P/E Ratio
BSTZ
3.64
TCBK
13.51
Forward P/E
BSTZ
--
TCBK
11.86
P/B Ratio
BSTZ
--
TCBK
1.22
P/S Ratio
BSTZ
--
TCBK
3.96
EV/EBITDA
BSTZ
--
TCBK
--

Profitability

Gross Margin
BSTZ
0.0%
TCBK
0.0%
Operating Margin
BSTZ
0.0%
TCBK
43.13%
Profit Margin
BSTZ
0.0%
TCBK
29.96%
ROE
BSTZ
--
TCBK
9.54%
ROA
BSTZ
--
TCBK
1.25%

Growth

Revenue Growth
BSTZ
--
TCBK
6.6%
Earnings Growth
BSTZ
--
TCBK
17.2%

Financial Health

Debt/Equity
BSTZ
--
TCBK
--
Current Ratio
BSTZ
--
TCBK
--
Quick Ratio
BSTZ
--
TCBK
--

Dividends

Dividend Yield
BSTZ
8.61%
TCBK
2.82%
Payout Ratio
BSTZ
42.06%
TCBK
37.3%

AI Verdict

BSTZ BEARISH

BSTZ exhibits extremely weak financial health with a Piotroski F-Score of just 1/9, indicating significant fundamental deterioration. Despite a low P/E of 3.64 and an intrinsic value estimate of $43.54, the absence of key financial data—especially profitability, balance sheet metrics, and cash flow—raises serious transparency concerns. The 8.61% dividend yield appears attractive but is undermined by zero profit margins and insider selling, while technical indicators signal strong bearish momentum. Combined with no analyst coverage and negative insider sentiment, BSTZ presents high risk despite apparent valuation discount.

Strengths
Low P/E ratio of 3.64 suggests potential undervaluation relative to earnings
High dividend yield of 8.61% may attract income-focused investors
Payout ratio of 42.06% appears sustainable if earnings are stable
Risks
Piotroski F-Score of 1/9 signals severe financial distress and weak fundamentals
Zero profit, operating, and gross margins suggest no operational profitability
Critical financial data missing (ROE, ROA, debt/equity, cash flow) limits analysis and raises transparency concerns
TCBK BULLISH

TCBK exhibits strong fundamental value with a Piotroski F-Score of 4/9 (Stable) and is trading significantly below both its Graham Number ($58.47) and estimated Intrinsic Value ($109.15). While the technical trend is heavily bearish (10/100), the company demonstrates robust earnings growth (17.2% YoY) and a consistent track record of beating analyst estimates. The valuation metrics, specifically the P/E of 13.51 and P/B of 1.22, suggest the stock is undervalued relative to its growth profile. However, the bearish price action and exposure to Commercial Real Estate (CRE) necessitate a cautious entry.

Strengths
Significant undervaluation relative to Graham Number and Intrinsic Value
Strong earnings growth (17.2% YoY) and consistent EPS beats (3/4 last 4 quarters)
Healthy ROA of 1.25%, which is a key efficiency metric for regional banks
Risks
Severe bearish technical trend (10/100) indicating strong short-term selling pressure
Exposure to Commercial Real Estate (CRE) and credit loss management under CECL
Moderate Piotroski F-Score (4/9) suggests room for improvement in financial health

Compare Another Pair

BSTZ vs TCBK: Head-to-Head Comparison

This page compares BlackRock Science and Technology Term Trust (BSTZ) and TriCo Bancshares (TCBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile